Results
1 -
10 of
14Valbenazine in tardive dyskinesia: a profile of its use, Drugs & Therapy Perspectives Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors, Drugs Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies, CNS Drugs Treatments for TD: limited evidence, high cost, PharmacoEconomics & Outcomes News ICER publishes draft report on 3??tardive dyskinesia therapies, PharmacoEconomics & Outcomes News Deuteriertes Tetrabenazin verringert unkontrollierte Bewegungen, InFo Neurologie & Psychiatrie ICER to review treatments for tardive dyskinesia, PharmacoEconomics & Outcomes News ICER posts scoping document on drugs for tardive dyskinesia, PharmacoEconomics & Outcomes News Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome, CNS Drugs Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine, Drugs in R&D